Component of bromelain

Details Component of bromelain Component of bromelain

2003-06-03

2010-11-16

Kemmerer, Elizabeth C. (Department: 1646)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S350000, C530S412000

Reexamination Certificate

active

07833963

ABSTRACT:
The invention relates to a component of bromelain which is largely responsible for the ability of bromelain to interrupt the MAP kinase cascade. The component contains ananain and comosain and is useful in the treatment or prevention of diseases and conditions mediated by T cell activation or by activation of the MAP kinase pathway.

REFERENCES:
patent: 4485095 (1984-11-01), Fujisaki et al.
patent: 5106621 (1992-04-01), Rowan et al.
patent: 5223406 (1993-06-01), Ransberger et al.
patent: 5260074 (1993-11-01), Sipos
patent: 5324514 (1994-06-01), Sipos
patent: 5356625 (1994-10-01), Ying
patent: 5387517 (1995-02-01), Cini
patent: 5460812 (1995-10-01), Sipos
patent: 5484609 (1996-01-01), Ko
patent: 5578304 (1996-11-01), Sipos
patent: 5578310 (1996-11-01), M'Timkulu et al.
patent: 5597564 (1997-01-01), Ying
patent: 5824305 (1998-10-01), Mynott
patent: 5928640 (1999-07-01), Mynott
patent: 6335427 (2002-01-01), Mynott et al.
patent: 2002/0188107 (2002-12-01), Mynott et al.
patent: 4302060 (1994-07-01), None
patent: 0313346 (1989-04-01), None
patent: 0576938 (1994-01-01), None
patent: 59-225122 (1984-12-01), None
patent: 02-16977 (1990-01-01), None
patent: 2001-513635 (2001-09-01), None
patent: 2001-513636 (2001-09-01), None
patent: WO 85/03438 (1985-08-01), None
patent: WO 88/01506 (1988-03-01), None
patent: WO 93/01800 (1993-02-01), None
patent: WO 94/00147 (1994-01-01), None
patent: WO 95/00169 (1995-01-01), None
patent: WO 96/00082 (1996-01-01), None
patent: WO 97/24138 (1997-01-01), None
patent: WO 98/38291 (1998-09-01), None
patent: WO 98/38319 (1998-09-01), None
patent: WO 98/38320 (1998-09-01), None
patent: WO 99/00141 (1999-01-01), None
patent: WO 00/14253 (2000-03-01), None
Taussig and Batkin, J. Ethnopharmacol., 1988, vol. 22(2), pp. 191-203.
Maurer, 2001, Cell. Mol. Life Sci., vol. 58, pp. 1234-1245.
Napper et al., Biochem. J., 1994, vol. 301, pp. 727-735.
Bocchino et al., Int. J. Tuberc Lung Dis., 2005, 9(4):375-383. (abstract).
Roberts et al., oncogene, 2007, 26(22):3291-3310.
Yao et al., Acta Biochim. Biophys. Sin. (shanghai), 2006, 38(4):249-253 (Abstract).
Hodge et al., Eur. J. Cancer, 2005, 41(16):2502-2512.
Purcell et al., Shock, 2006, 25(2):135-40 (Abstract).
Hayrinen-Immonen, Scand. J. Dent. Res., 1992, 100(4):222-227 (Abstract).
Barshes et al., Front. Biosci. 2004, 9:411-20.
Lee et al., J. Leukoc. Biol., vol. 59(2):152-157.
Harrach et al., J. Prot. Chem., 1995, vol. 14(1):41-52.
Belham et al.,Biochem. J., 320: 939-946 (1996).
Bliska et al.,Cell, 73: 903-920 (1993).
Cantrell,Annu. Rev. Immunol., 14: 259-274 (1996).
Filippova et al.,Anal. Biochem, 143: 293-297 (1984).
Galan et al.,Nature, 357: 588-589 (1992).
Harrach et al.,J. Protein Chemistry, 14(1): 41-52 (1995).
Maurer et al.,Planta Medica, 377-381 (1988).
Munzig et al.,FEBS Letters, 351: 215-218 (1994).
Perandones et al.,J. Immunol, 151 (7): 3521-3529 (1993).
Rowan et al.,Archives of Biochem. and BioPhys., 267(1): 262-270 (1988).
Rowan et al.,Methods in Enzymology, 244: 555-568 (1994).
Taussig et al.,Planta Medica, 538-539 (1985).
Vouret-Craviari et al.,Biochem. J., 289: 209-214 (1993).
Avruch et al.,Trends Biochem Sci., 19: 279-283 (1994).
Fang,ASM News, 63: 668-673 (1997).
Fox,Intl. Immunol., 5: 343-330 (1993).
Garbin et al.,Intl. J. Oncol., 5: 197-203 (1994).
Gillis et al.,J. Immunol., 120: 2027-2032 (1978).
Hibbs,Res. Immunol., 142: 565-569 (1991).
Izquierdo et al.,Mol. Cell. Biol., 12: 3305-3312 (1992).
Izquierdo et al.,J. Exp. Med., 178: 1199-1208 (1993).
June et al.,J. Immunol., 144: 1591-1599 (1990).
June et al.,PNAS, 87: 7722-7726 (1990).
Kaye et al.,Infection and Immunity, 60: 4335-4342 (1992).
Kelland et al.,Cancer Res., 53: 2581-2586 (1993).
Lotz-Winter,Planta Medica, 56(3): 249-253 (1990).
Lowry et al.,J. Biol. Chem., 193: 265-275 (1951).
Muta et al., EMBL/GenBank/DDBJ Databases, Accession No. O23791, submitted Jan. 1993, updated Jan. 1, 1998, created Jan. 24, 2006.
Muta et al., EMBL/GenBank/DDBJ Databases, Accession No. O23801, submitted Oct. 1994, updated Jan. 1, 1998, created Jan. 1, 1998.
Ota et al.,J. Biochem., 98: 219-228 (1985).
Rayter et al.,EMBO J., 11: 4549-4556 (1992).
Roach et al.,Infection and Immunity, 59: 3935-3944 (1991).
Sagar et al.,Cancer Treatment Rev., 21: 159-181 (1995).
Seifert et al.,Acta Pharm. Technol., 34: 55-62 (1988).
Truneh et al.,Nature, 31(3): 318-320 (1985).
Mynott et al.,Gastroenterology, 113: 175-184 (1997).
Barlow,Burns, 20(6): 487-90 (1994).
Church et al.,Clin. Microbiol. Rev., 19(2): 403-34 (Apr. 2006).

Affiliated with

Also associated with

Rating

Component of bromelain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Component of bromelain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Component of bromelain will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4195500